A detailed history of Covestor LTD transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Covestor LTD holds 4 shares of SNDX stock, worth $66. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 5 20.0%
Holding current value
$66
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$17.93 - $24.81 $17 - $24
-1 Reduced 20.0%
4 $0
Q4 2023

Feb 09, 2024

SELL
$11.39 - $21.67 $11 - $21
-1 Reduced 16.67%
5 $0
Q2 2023

Aug 11, 2023

SELL
$19.35 - $22.31 $251 - $290
-13 Reduced 68.42%
6 $0
Q1 2023

May 15, 2023

BUY
$20.66 - $28.98 $103 - $144
5 Added 35.71%
19 $0
Q4 2022

Feb 13, 2023

SELL
$20.64 - $26.24 $20 - $26
-1 Reduced 6.67%
14 $0
Q3 2022

Nov 14, 2022

BUY
$18.51 - $24.79 $55 - $74
3 Added 25.0%
15 $0
Q2 2022

Aug 10, 2022

BUY
$13.64 - $19.48 $163 - $233
12 New
12 $0
Q1 2022

May 13, 2022

SELL
$14.84 - $22.15 $0 - $0
0 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$15.23 - $22.47 $0 - $0
0 New
0 $0

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $946M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.